The Oncology Institute Inc (TOI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


The Oncology Institute Inc   (NASDAQ: TOI)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


The Oncology Institute Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is The Oncology Institute Inc's ROI in the second quarter of 2026?
The Oncology Institute Inc recorded a cumulative net loss of $-27 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -29.75%.

Within the Healthcare sector 358 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3404 to 3557.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -19.56 % -25.16 % -29.66 % -31.49 % -34.28 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 83 89 94 98 95
Return On Investment (TTM) -29.75 % -34.94 % -51.43 % -46.76 % -45.28 %
TOI's Overall Ranking # 3557 # 3404 # 2764 # 3184 # 2754
Seq. Investment Change TTM -3.12 % -3.98 % -6.41 % -7.6 % -9.86 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -33 -50 -49 -51




Return On Investment TOI's Ranking
Within: No.
Industry # 28
Sector # 359
Overall # 3557

Return On Investment Statistics
High Average Low
5.96 %
-21.03 %
-51.43 %
(Dec 31 2022)   (Dec 31 2025)



  News about The Oncology Institute Inc Return on Investment ROI

Jordan McInerney Joins The Oncology Institute as Chief Development Officer, Brings Expertise to Tackle Negative ROI and Propel Value-Based Specialty Care Models

April 8, 2024


The Oncology Institute, Inc. has recently appointed Jordan McInerney as their Chief Development Officer. The move comes at a crucial time for the company, as it recorded a cumulative net loss of $-68 million during the 12 months ending in the fourth quarter of 2023. This has resulted in a negative return on investment (ROI) of -35.66%.
McInerney s appointment brings a ray of hope for the company, as he has a wealth of experience in advancing value-based specialty care models. With this expertise, he can play a crucial role in formulating strategies to turn the company s financial performance around.






Financial Statements
The Oncology Institute Inc's II. Quarter Investments $ 83 Millions TOI's Balance sheet
The Oncology Institute Inc's II. Quarter Income $ -8 Millions Quarterly TOI's Income Statement
TOI's Income by Division See TOI's Income by Division


TOI Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 94 121 174 232 174
Y / Y Investment Growth -22.25 % -30.93 % -24.79 % 33.58 % -24.85 %
Net Income in Millions -50 -53 -68 0 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -53.69 % -43.99 % -38.91 % 0.03 % -6.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TOI's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TOI's Competitors
Subscribers only: Roi for The Oncology Institute Inc's Suppliers
Subscribers only: Return On Investment for TOI's Customers

Other Ratios
TOI's Roa TOI's Inventory Turnover Ratio TOI's Growth Rates TOI's Dividend Statistics
TOI's Profitability Ratios TOI's Asset Turnover Ratio TOI's Dividend Growth
TOI's Roe TOI's Valuation Ratios TOI's Financial Strength Ratios TOI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:38:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.